COVID‐19 in gastroenterology: Where are we now? Current evidence on the impact of COVID‐19 in gastroenterology

Author:

Magro Fernando123ORCID,Nuzzo Alexandre4ORCID,Abreu Cândida56,Libânio Diogo78ORCID,Rodriguez‐Lago Iago9ORCID,Pawlak Katarzyna10ORCID,Hollenbach Marcus11ORCID,Brouwer Willem P.12,Siau Keith13

Affiliation:

1. Department of Biomedicine, Unit of Pharmacology and Therapeutics University of Porto Porto Portugal

2. Department of Gastroenterology Centro Hospitalar São João Porto Portugal

3. Unit of Clinical Pharmacology Centro Hospitalar São João Porto Portugal

4. Department of Gastroenterology, IBD & Intestinal Failure APHP Beaujon Hospital University of Paris Clichy France

5. Infectious Diseases Service Centro Hospitalar São João Porto Portugal

6. Department of Medicine Grupo de I&D em Nefrologia e Doenças Infeciosas Instituto de Inovação e Investigação em Saúde (I3s) Instituto Nacional de Engenharia Biomédica (INEB) Faculty of Medicine University of Porto Porto Portugal

7. Gastroenterology Department Portuguese Oncology Institute of Porto Porto Portugal

8. MEDCIDS ‐ Department of Community Medicine, Health Information and Decision Faculty of Medicine University of Porto Porto Portugal

9. Gastroenterology Department IBD Unit Hospital de Galdakao Biocruces Bizkaia Health Research Institute and School of Medicine University of Deusto Galdakao Spain

10. Department of Gastroenterology Endoscopy Unit Hospital of the Ministry of Interior and Administration Szczecin Poland

11. Medical Department II Division of Gastroenterology University of Leipzig Medical Center Leipzig Germany

12. Department of Gastroenterology & Hepatology Erasmus University Medical Center Rotterdam The Netherlands

13. Department of Gastroenterology Dudley Group Hospitals NHS Foundation Trust Dudley UK

Publisher

Wiley

Subject

Gastroenterology,Oncology

Reference171 articles.

1. Origin and evolution of pathogenic coronaviruses

2. World Health Organization. COVID‐19 weekly epidemiological update on COVID‐19 ‐ 20 April 2021.2021.https://www.who.int/publications/m/item/weekly‐epidemiological‐update‐on‐covid‐19‐‐‐20‐april‐2021

3. The socio-economic implications of the coronavirus pandemic (COVID-19): A review

4. The emotional impact of COVID-19: From medical staff to common people

5. COVID-19: Disease, management, treatment, and social impact

Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. UEG onwards & upwards: A president's perspective;United European Gastroenterology Journal;2024-01-05

2. Telemedicine in inflammatory bowel disease from its origin to the post pandemic golden age: A narrative review;Digestive and Liver Disease;2024-01

3. SARS-CoV-2 Hangi Dokularda Patolojiye Neden Oluyor?;Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi;2023-11-20

4. Markers of Local and Systemic Inflammation in the Diarrhea Syndrome Associated with the Coronavirus Disease (COVID-19);ЗДОРОВЬЕ НАСЕЛЕНИЯ И СРЕДА ОБИТАНИЯ - ЗНиСО / PUBLIC HEALTH AND LIFE ENVIRONMENT;2023-10

5. Impact of COVID-19 in individuals with and without pre-existent digestive disorders with a particular focus on elderly patients;World Journal of Gastroenterology;2023-07-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3